Madeleine O'Neill is a Courts Reporter for The Daily Record, focusing on local news in Maryland, specifically in Baltimore. She covers a wide range of topics related to the legal system, including court cases, judicial decisions, and legal issues affecting the community.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Baltimore, United States (Local)
Not enough data
Madeleine O'Neill's coverage is heavily focused on legal news, particularly concerning Maryland and Baltimore. She concentrates on court cases, attorney discipline, and government announcements related to legal policy regulation. Given her focus, she would likely be receptive to pitches from lawyers or legal experts with insights into local court cases, attorney discipline issues in Maryland or Baltimore.
Additionally, given the emphasis on government & politics as well as crime-related topics, relevant sources such as local policymakers and law enforcement officials could also capture her interest. If pitching a story related to these areas of coverage, it should have a direct tie-in to Maryland or Baltimore's legal landscape.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Madeleine O Neill
The City of Baltimore has reached an $80 million settlement with Teva Pharmaceuticals, one of the defendants in the city's ongoing lawsuit against drug manufacturers and distributors accused of contributing to the opioid crisis.
Details of the settlement remain secret, unlike previous opioid settlements that the city has announced in recent weeks. Two companies remain in the city's lawsuit against opioid firms, and the trial is scheduled to begin today.
The arguments from attorney Bill Carmody were part of opening statements Wednesday, setting the stage for how the city and opioid companies will approach the planned eight-week trial.
By: Madeleine O'Neill
“There’s no reasonable explanation that I can imagine that would explain this amount in a city the size of Baltimore,” a former DEA agent testified Tuesday.
By: Madeleine O'Neill
Baltimore joined that exclusive group last month, launching a trial against the drug distributors McKesson and AmerisourceBergen that has been six years in the making.
By: Madeleine O Neill
Big pharmacies like Drug City ordered large quantities of opioids, he agreed, but they also bought large quantities of other drugs, like blood pressure medication. (Drug City was McKesson's top buyer of oxycodone nationwide among independent pharmacies, according to evidence presented at the trial, purchasing 11.6 million opioids in less than six years before McKesson terminated the pharmacy as a customer in 2012.)
Police files released in response to a public records request shed new light on the western Maryland shooting death of Judge Andrew Wilkinson.
By: Madeleine O Neill
The opioid trial is far from over, though. The distributors, McKesson and AmerisourceBergen, will begin presenting their cases this week. The trial is expected to continue into next month.
By: Madeleine O'Neill
The decision is a blow to the city and a win for the drug companies, but it was not entirely unexpected because of Maryland’s high legal standard for punitive damages.
By: Madeleine O'Neill
Attorneys said Susman Godfrey is known for its innovative approach and that adversaries know it isn't bluffing about taking cases to trial.
(833) 317-6278 
